Surrogate measures and consistent surrogates
From MaRDI portal
Recommendations
Cites work
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Comparing biomarkers as principal surrogate endpoints
- Evaluating Candidate Principal Surrogate Endpoints
- On meta-analytic assessment of surrogate outcomes
- Principal stratification in causal inference
- Properties of monotonic effects on directed acyclic graphs
- Related Causal Frameworks for Surrogate Outcomes
- Simple relations between principal stratification and direct and indirect effects
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Cited in
(42)- Surrogate models in ill-conditioned systems
- Surrogate outcomes and transportability
- Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process
- A general framework to assess complex heterogeneity in the strength of a surrogate marker
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference
- Novel criteria to exclude the surrogate paradox and their optimalities
- On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints
- Robust methods to correct for measurement error when evaluating a surrogate marker
- Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers
- Evaluating surrogate marker information using censored data
- Assessing a surrogate predictive value: a causal inference approach
- Towards optimal use of surrogate markers to improve power
- Power of testing for exposure effects under incomplete mediation
- Criteria for multiple surrogates
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
- Robust Approach to Combining Multiple Markers to Improve Surrogacy
- Evaluation of longitudinal surrogate markers
- Causal measures of the treatment effect captured by candidate surrogate endpoints
- Assessing heterogeneity in surrogacy using censored data
- Data fusion for predicting long-term program impacts
- Flexible evaluation of surrogate markers with Bayesian model averaging
- Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm
- Using a surrogate with heterogeneous utility to test for a treatment effect
- Proportion of treatment effect mediated by surrogate endpoints
- Surrogacy validation for time-to-event outcomes with illness-death frailty models
- Semiparametric pseudo-score and pseudo-likelihood for evaluating correlate of protection in vaccine trials
- Evaluating multiple surrogate markers with censored data
- Avoiding the surrogate paradox: an empirical framework for assessing assumptions
- Testing for Heterogeneity in the Utility of a Surrogate Marker
- Estimation of the proportion of treatment effect explained by a high-dimensional surrogate
- Identifying surrogate markers in real-world comparative effectiveness research
- Decomposition and interpretation of treatment effects in settings with delayed outcomes
- Semiparametric localized principal stratification analysis with continuous strata
- Assessing the value of a censored surrogate outcome
- Model-free approach to evaluate a censored intermediate outcome as a surrogate for overall survival
- Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design
- Surrogate marker evaluation: a tutorial using R
- Robust evaluation of longitudinal surrogate markers with censored data
- On the role of surrogates in the efficient estimation of treatment effects with limited outcome data
- Long-term causal inference under persistent confounding via data combination
- Validation of a longitudinal marker as a surrogate using mediation analysis and joint modeling: evolution of the PSA as a surrogate of the disease-free survival
This page was built for publication: Surrogate measures and consistent surrogates
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2861938)
